Patent application number | Description | Published |
20080238176 | Synthetic yarn having a multi-yarn effect - Synthetic yarns are formed from polymer materials which preferably are self-twisted to give a multi-yarn effect. The yarns are used to form woven panels for use in furniture. The single strand yarns have the appearance of multiple strands, while saving on the heating and twisting involved with handling multiple strands. | 10-02-2008 |
20090045667 | Single frame sling chair - A sling chair includes a back frame member having side rails held in substantially parallel relation by a pair of cross bar members. In one embodiment, the cross bar members are generally curved so as to extend away from the back faces of the side rails, forming a concave back structure which can receive a sling member and, eventually, a seated occupant. The cross bar members are adapted to retain the sling member in secure fashion through upper and lower backrest assemblies, resulting in better support and more efficient assembly. This also facilitates separate provisioning of decorative features to improve the chair's aesthetic qualities. | 02-19-2009 |
20090120334 | Tabletop for Outdoor Use Having Metal Frame - A tabletop for use on an outdoor table is disclosed. A metal frame having at least one horizontally oriented transverse member defines the general shape of the tabletop. A fiber fabric layer is affixed to the top of the transverse member. A decorative layer comprising a plurality of spaced apart decorative elements provides the outer surface of the table top. A mesh layer is positioned between the fiber fabric layer and the decorative layer. The elements are adhered together by a binder comprised of adhesive material. The binder is interposed between and contacting the at least one transverse member and the decorative layer so that the layers of fiber fabric and mesh are embedded within the binder and the decorative layer is fixedly adhered to the at least one horizontally oriented transverse member. | 05-14-2009 |
20090217845 | Sling table - A sling table is disclosed having a transparent top and a decorative fabric sling visible through the transparent table top. A frame defines an inner opening of a desired shape. The transparent table top is mounted to the frame in a substantially horizontal orientation. The fabric sling is mounted to the frame within the inner opening via sling rods. The fabric of the sling may match or complement fabric of other pieces of furniture, and may be replaced without having to replace the table top. | 09-03-2009 |
20100207437 | Swivel rocker chair and assembly - A swivel rocker chair connection assembly facilitates construction of a swivel rocker chair and allows for the secure and stable operation of the chair. The chair includes a base portion, a seat portion and a connection assembly having at least one dual washer plate adapted to engage one or more rocker spring members positioned and engaged with the chair base and seat portions. | 08-19-2010 |
20100270843 | Single frame sling chair - A sling chair includes a back frame member having side rails held in substantially parallel relation by a pair of cross bar members. In one embodiment, the cross bar members are generally curved so as to extend away from the back faces of the side rails, forming a concave back structure which can receive a sling member and, eventually, a seated occupant. The cross bar members have a notch allowing for insertion of a flexible rod and sling loop and sling member after assembly of the cross bar members and side rails. Insertion of the flexible rod and sling loop does not require tools. The cross members are adapted to retain the sling member in secure fashion through upper and lower backrest assemblies, resulting in better support and more efficient assembly. This also facilitates separate provisioning of decorative features to improve the chair's aesthetic qualities. | 10-28-2010 |
20110079064 | DECORATIVE HOLLOW TUBING FOR USE IN FURNITURE MANUFACTURE AND METHOD FOR MANUFACTURING - Hollow decorative tubing fabricated from thin walled metallic stock material, the stock material preferably being stock tubing. Tubing is cold worked to impart any desired design such as simulated bamboo having realistic culm and node characteristics. The tubing is preferably formed into serial or repeating sections, each characterized by the desired design. For simulated bamboo, a realistic node is worked into the tubing between adjacent sections. The invention may be regarded as a method for manufacturing the resultant elongate hollow decorative tubing or, alternatively, an article of manufacture such as a chair incorporating the resultant elongate simulated bamboo article. | 04-07-2011 |
20110151256 | Synthetic yarn - A synthetic wicker yarn with irregularities sufficient to simulate natural wickers, in which the irregularities are durable even during weaving. The yarn is formed from an elongated body with a generally round cross section. The body is of two layers of coextruded polymer an outer layer integrated around the inner layer. An irregular node having a protuberance formed of the polymer outer layer extends radially from the outer layer, with a clearance exposing the polymer inner layer, in a manner like decorticated wicker. The outer layer may be have a greater density and rigidity for durability of the irregularity. Also included is a method of manufacturing this yarn and furniture having the yarn. | 06-23-2011 |
20110151257 | Synthetic yarn - A synthetic wicker yarn capable of simulating a rolled leaf style, while being adapted to facilitate weaving. The yarn has an extruded, elongated body fabricated from a blend of a plurality of foamed polymers. The body has a surface of a first color, an x-axis and y-axis along a cross-sectional portion of the elongated body, and a longitudinal z-axis along its length. The x-axis has a first effective diameter and the y-axis has a second effective diameter. The body includes at least two rounded, foamed polymer folds, which project transversely from the x-axis and run longitudinally along a portion of the body. These folds simulate the margins of a leaf wrapped into a roll. Between the folds is a substantially concave crease within the surface of the body, also oriented longitudinally. The effective diameters are configured to form a substantially elliptical cross section that is easy to weave. | 06-23-2011 |
Patent application number | Description | Published |
20090275598 | Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders - The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: | 11-05-2009 |
20090275659 | Phenyl acetic acid derivatives as inflammation modulators - Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of inflammatory and immune-related diseases and conditions. In particular, the invention provides compounds which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer. The subject compounds are carboxylic acid derivatives. | 11-05-2009 |
20100075974 | HETEROCYCLIC GPR40 MODULATORS - The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: | 03-25-2010 |
20100137323 | BENZO-FUSED COMPOUNDS FOR USE IN TREATING METABOLIC DISORDERS - The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: | 06-03-2010 |
20100298367 | Conformationally Constrained Carboxylic Acid Derivatives Useful for Treating Metabolic Disorders - The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I or the general formula III: | 11-25-2010 |
20110190330 | SPIROCYCLIC GPR40 MODULATORS - The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula IA, IB, I′A or I′B: | 08-04-2011 |
20110319378 | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER - The present invention provides MDM2 inhibitor compounds of Formula I, | 12-29-2011 |
20140315895 | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER - The present invention provides MDM2 inhibitor compounds of Formula I, | 10-23-2014 |
Patent application number | Description | Published |
20120108796 | Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI) - Isolated monoclonal antibodies that bind human tissue factor pathway inhibitor (TFPI) are provided. Isolated nucleic acid molecules encoding monoclonal antibodies that bind TFPI are also contemplated. Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided. Methods of producing the antibodies are also provided. | 05-03-2012 |
20120329996 | Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI) - Isolated monoclonal antibodies that bind human tissue factor pathway inhibitor (TFPI) are provided. Isolated nucleic acid molecules encoding monoclonal antibodies that bind TFPI are also contemplated. Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided. Methods of producing the antibodies are also provided. | 12-27-2012 |
20140275493 | ANTI-TFPI ANTIBODY VARIANTS WITH DIFFERENTIAL BINDING ACROSS PH RANGE FOR IMPROVED PHARMACOKINETICS - Antibodies are disclosed that bind to and inhibit the anti-coagulant function of TFPI and have a lower affinity for TFPI at pH 6.0 than at pH 7.4. The lower affinity at pH 6 improves circulating half-life (T½) due to reduced target mediated clearance, a process by which an antibody/antigen complex is endocytosed and trafficked to the lysosome where both components are degraded. The lower affinity at pH 6.0 results in disruption of the complex prior to lysosome targeting and allows for re-circulation of the antibody. Specific modifications to antibody binding by histidine residue substitution are disclosed along with methods of use. | 09-18-2014 |
20140294832 | MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI) - Isolated monoclonal antibodies that bind to specific epitopes of human tissue factor pathway inhibitor (TFPI) and the isolated nucleic acid molecules encoding them are provided. Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided. | 10-02-2014 |
20150064169 | PROTEASE-REGULATED ANTIBODIES - This disclosure provides protease-regulated antibodies which specifically bind to tissue factor pathway inhibitor (TFPI). The antibodies are useful for treating bleeding disorders such as hemophilia. | 03-05-2015 |